Literature DB >> 19053869

Phytate (myo-inositol hexaphosphate) and risk factors for osteoporosis.

A A López-González1, F Grases, P Roca, B Mari, M T Vicente-Herrero, A Costa-Bauzá.   

Abstract

Several risk factors seem to play a role in the development of osteoporosis. Phytate is a naturally occurring compound that is ingested in significant amounts by those with diets rich in whole grains. The aim of this study was to evaluate phytate consumption as a risk factor in osteoporosis. In a first group of 1,473 volunteer subjects, bone mineral density was determined by means of dual radiological absorptiometry in the calcaneus. In a second group of 433 subjects (used for validation of results obtained for the first group), bone mineral density was determined in the lumbar column and the neck of the femur. Subjects were individually interviewed about selected osteoporosis risk factors. Dietary information related to phytate consumption was acquired by questionnaires conducted on two different occasions, the second between 2 and 3 months after performing the first one. One-way analysis of variance or Student's t test was used to determine statistical differences between groups. Bone mineral density increased with increasing phytate consumption. Multivariate linear regression analysis indicated that body weight and low phytate consumption were the risk factors with greatest influence on bone mineral density. Phytate consumption had a protective effect against osteoporosis, suggesting that low phytate consumption should be considered an osteoporosis risk factor.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19053869     DOI: 10.1089/jmf.2008.0087

Source DB:  PubMed          Journal:  J Med Food        ISSN: 1096-620X            Impact factor:   2.786


  15 in total

Review 1.  The interaction between dietary protein and bone health.

Authors:  David Jesudason; Peter Clifton
Journal:  J Bone Miner Metab       Date:  2010-10-26       Impact factor: 2.626

2.  Protective effect of myo-inositol hexaphosphate (phytate) on bone mass loss in postmenopausal women.

Authors:  Angel A López-González; Félix Grases; Nieves Monroy; Bartolome Marí; Ma Teófila Vicente-Herrero; Fernando Tur; Joan Perelló
Journal:  Eur J Nutr       Date:  2012-05-22       Impact factor: 5.614

3.  A phase 1b randomized, placebo-controlled clinical trial with SNF472 in haemodialysis patients.

Authors:  Carolina Salcedo; Pieter H Joubert; Miguel D Ferrer; Ana Z Canals; Francisco Maduell; Vicens Torregrosa; Josep Maria Campistol; Raquel Ojeda; Joan Perelló
Journal:  Br J Clin Pharmacol       Date:  2019-02-19       Impact factor: 4.335

4.  First-time-in-human randomized clinical trial in healthy volunteers and haemodialysis patients with SNF472, a novel inhibitor of vascular calcification.

Authors:  J Perelló; P H Joubert; M D Ferrer; A Z Canals; S Sinha; C Salcedo
Journal:  Br J Clin Pharmacol       Date:  2018-10-03       Impact factor: 4.335

5.  Diet-derived fruit and vegetable metabolites show sex-specific inverse relationships to osteoporosis status.

Authors:  Kelsey M Mangano; Sabrina E Noel; Chao-Qiang Lai; Jacob J Christensen; Jose M Ordovas; Bess Dawson-Hughes; Katherine L Tucker; Laurence D Parnell
Journal:  Bone       Date:  2020-12-02       Impact factor: 4.398

6.  Essential Nutrients for Bone Health and a Review of their Availability in the Average North American Diet.

Authors:  Charles T Price; Joshua R Langford; Frank A Liporace
Journal:  Open Orthop J       Date:  2012-04-05

7.  Inositol hexakisphosphate inhibits osteoclastogenesis on RAW 264.7 cells and human primary osteoclasts.

Authors:  María del Mar Arriero; Joana M Ramis; Joan Perelló; Marta Monjo
Journal:  PLoS One       Date:  2012-08-14       Impact factor: 3.240

8.  Enzymatic activity of Lactobacillus reuteri grown in a sweet potato based medium with the addition of metal ions.

Authors:  Saeed A Hayek; Aboghasem Shahbazi; Mulumebet Worku; Salam A Ibrahim
Journal:  Springerplus       Date:  2013-09-16

9.  Dietary mineral supplies in Africa.

Authors:  Edward J M Joy; E Louise Ander; Scott D Young; Colin R Black; Michael J Watts; Allan D C Chilimba; Benson Chilima; Edwin W P Siyame; Alexander A Kalimbira; Rachel Hurst; Susan J Fairweather-Tait; Alexander J Stein; Rosalind S Gibson; Philip J White; Martin R Broadley
Journal:  Physiol Plant       Date:  2014-02-13       Impact factor: 4.500

10.  A novel pharmacodynamic assay to evaluate the effects of crystallization inhibitors on calcium phosphate crystallization in human plasma.

Authors:  M D Ferrer; M M Pérez; M M Cànaves; J M Buades; C Salcedo; J Perelló
Journal:  Sci Rep       Date:  2017-07-31       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.